Transforming Discovery into Opportunity

In order to recognize the contributions of CDRD’s many partners across academia, industry, government and foundations, and to share some of our recent successes and future plans with the community, we invite you to join us on May 26th for a special luncheon and open house.

Details here…

 

CDRD spin-out company, Kairos Therapeutics, has entered merged with Zymeworks!

Read more…

In total, over one-third of all the life science companies included in the 2016 Ready to Rocket and Emerging Rocket Life Sciences lists have received support, mentorship and/or expertise from CDRD.

Find out how CDRD is fueling emerging companies that are ready to rocket!

Health sciences researchers, entrepreneurs, and companies alike have the opportunity to collaborate with CDRD and thereby access its full suite of expertise, infrastructure, and broad partnerships and networks.

Find out how CDRD supports Canadian Small/Medium Enterprises (SMEs)……

Karimah Es Sabar, our President and CEO, was honoured with a 2016 Influential Women in Business Award! Other honourees included (l-r) Marcia Smith, Karina Brino, Eva Lee Kwok, Karimah, Michelle Pockey and Evi Mustel.

Read more…

Introducing Zucara Therapeutics Inc., a new start-up company created by MaRS Innovation and CDRD.

Zucara is developing a novel drug therapy to reduce the severity and frequency of hypoglycemic (low blood sugar) episodes in people with diabetes.

Read more…

Thank you to the Honourable Kirsty Duncan, Parliamentary Secretary Terry Beech and the Honourable Dr. Hedy Fry for touring CDRD and meeting many of our staff and trainees.

CDRD is a proud sponsor of the 16th IUBMB Conference in Vancouver, from July 17-21, 2016.

More details…

CDRD BY THE NUMBERS:

  • Over 1,100 early-stage technologies evaluated for commercial potential
  • Over 200 projects on 134 distinct technologies
  • 56 technologies advanced toward commercialization and/or commercialized
  • 7 spin-off companies launched
  • 14 technologies out-licensed

What is CDRD?

Headquartered in Vancouver, British Columbia, The Centre for Drug Research and Development (CDRD) is Canada’s national drug development and commercialization engine.

We work in partnership with academia, industry, government and foundations, to provide the specialized expertise and infrastructure to identify and de-risk promising discoveries generated by health-related research, and transform them into commercially viable investment opportunities for the private sector – and ultimately into innovative new therapies for patients.

In doing so, CDRD is actively growing our national health sciences industry into a wholly-optimized generator of economic prosperity for the country.

Since 2008, Canada’s Networks of Centres of Excellence Program has recognized CDRD as a Centre of Excellence for Commercialization and Research (CECR).

Latest from the Blog

Joint article by CDRD & global collaboration group published in Nature Reviews Drug Discovery

CDRD helps fuel emerging companies that are ready to rocket!

+ VISIT THE BLOG

Latest from Twitter


+ FOLLOW US ON TWITTER



A Shared Vision










  • Industry
  • Academia
  • Government

Sign up to our newsletter

Receive CDRD's e-newsletter, The CDRD Pipeline and other e-communications for regular updates on all our news and activities.



© Copyright 2016 CDRD. All rights reserved.

>